MSN -- LONDON — Scientists seeking treatments for a deadly type of skin cancer say an existing arthritis drug slows the growth of melanomas and could be combined with a drug being developed by Plexxikon and Swiss drugmaker Roche. In laboratory studies using mice and human cancer cells the researchers found that leflunomide, a generic drug commonly used to treat rheumatoid arthritis, also inhibits the growth of melanomas.
